← TrialMatch
HomeTrials

The Clinical Course and Factors for the Progression of Uninvestigated Dyspepsia to Functio

Dyspepsia is one of the most common gastrointestinal diseases. This disease was defined as predominant epigastric pain lasting for at least 1 month, which can be accompanied with other symptoms, such as epigastric fullness, and early satiety. Despite dyspepsia symptoms lasting for ≥1 month represented clinical problem,

Condition(s)Dyspepsia
StatusRecruiting
Study typeObservational
SummaryDyspepsia is one of the most common gastrointestinal diseases. This disease was defined as predominant epigastric pain lasting for at least 1 month, which can be accompanied with other symptoms, such as epigastric fullness, and early satiety. Despite dyspepsia symptoms lasting for ≥1 month represented clinical problem, a longer duration of 6 months or more after first-onset symptom was required for the diagnosis of functional dyspepsia based on ROME IV criteria. It was unclear about the natural procession of first-onset dyspepsia to functional dyspepsia assessed by Rome IV or Asia criteria and possible factors associated with this progression.
Who can participateInclusion Criteria: * Patients aged ≥ 18 years old who had first-onset dyspepsia with one or more symptoms of epigastric pain, epigastric burning, postprandial fullness, early satiation and that has lasted for more than 1 month to 3 months. Exclusion Criteria: 1. Patients with local or systemic diseases which may cause dyspeptic symptoms: Known active peptic ulcer, cholecystitis, gallstone, gastrointestinal obstruction, gastroparesis, and etc. 2. Known acute or chronic injury of liver or kidney 3. Obvious hematological abnormality, or endocrine and metabolic diseases 4. Known malignancy; Obvious cardiovascular or cerebrovascular diseases (such as coronary heart disease, arrhythmia, cerebral infarction and etc. 5. Other conditions which may be associated with dyspeptic symptoms (such as NSA
Ages18 Years
SexAll
Lead sponsorAir Force Military Medical University, China
LocationsXi'an, Shaanxi, China
Start date2023-01-01
NCT IDNCT05823636
Official listinghttps://clinicaltrials.gov/study/NCT05823636

🔍 Search all trials →